Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Novartis
Chubb
Teva
AstraZeneca
Express Scripts
US Department of Justice
Cipla
Julphar
Medtronic

Generated: February 21, 2018

DrugPatentWatch Database Preview

Rifampin - Generic Drug Details

« Back to Dashboard

What are the generic sources for rifampin and what is the scope of rifampin freedom to operate?

Rifampin
is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Akorn, Lannett, Lupin Pharms, Sandoz, Oxford Pharms, Emcure Pharms Ltd, Fresenius Kabi Usa, Hikma Pharms, Mylan Labs Ltd, Watson Pharms Teva, and West-ward Pharms Int, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for rifampin. Twenty-six suppliers are listed for this compound.

US Patents and Regulatory Information for rifampin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Pharms Teva RIFAMPIN rifampin INJECTABLE;INJECTION 206736-001 Jan 19, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn RIFAMPIN rifampin CAPSULE;ORAL 065028-002 Mar 14, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Pharms RIFAMPIN rifampin INJECTABLE;INJECTION 205039-001 Mar 3, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn RIFAMPIN rifampin CAPSULE;ORAL 065028-001 Mar 14, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett RIFAMPIN rifampin CAPSULE;ORAL 065390-002 Mar 28, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin Pharms RIFAMPIN rifampin CAPSULE;ORAL 090034-001 Aug 21, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us RIFADIN rifampin CAPSULE;ORAL 050420-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett RIFAMPIN rifampin CAPSULE;ORAL 065390-001 Mar 28, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz RIFAMPIN rifampin CAPSULE;ORAL 064150-001 May 28, 1997 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz RIFAMPIN rifampin CAPSULE;ORAL 064150-002 Jan 2, 1998 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Teva
Argus Health
Citi
Express Scripts
Covington
QuintilesIMS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot